CS
WINT

Credit Suisse’s Windtree Therapeutics Inc WINT Stock Holding History

Credit Suisse’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2,189
Closed -$36K – 4723
2015
Q1 		$36K Sell
2,189
-5,100
-70% -$100K ﹤0.01% 4299
2014
Q4 		$118K Buy
+7,289
New +$160K ﹤0.01% 4405
2014
Q3 		– Sell
-2,284
Closed -$57K – 4787
2014
Q2 		$57K Sell
2,284
-7,987
-78% -$204K ﹤0.01% 4588
2014
Q1 		$309K Buy
+10,271
New +$346K ﹤0.01% 4075
2013
Q3 		– Sell
-4,548
Closed -$97K – 4470
2013
Q2 		$97K Buy
+4,548
New +$112K ﹤0.01% 4025

Other funds holding WINT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Credit Suisse's WINT Position: Q2 2015 in Review

Credit Suisse sold out of Windtree Therapeutics Inc (WINT) in Q2 2015, closing a stake of 2,189 shares — an estimated $36K sold.

Credit Suisse first reported a position in WINT in Q2 2013 and held it in 5 quarters. The position peaked at $309K in Q1 2014. 52 funds tracked by Wall St. Rank hold WINT as of Q2 2015.

  • Credit Suisse reported no remaining Windtree Therapeutics Inc position as of Q2 2015 after selling out during the quarter.
  • Credit Suisse sold 2,189 Windtree Therapeutics Inc shares in Q2 2015, an estimated $36K.
  • Credit Suisse first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 5 quarters.
  • Credit Suisse's Windtree Therapeutics Inc position peaked at $309K in Q1 2014.
  • 52 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2015.

Based on Credit Suisse's 13F filing for Q2 2015, filed 13 Aug 2015.